Orphenadrine Citrate
Catalog No.
B1606
Antiparkinsonian and analgesic drug
Featured Products
Orphenadrine has been used as an antiparkinsonian, antispastic and analgesic drug. Orphenadrine inhibits [3H]MK-801 binding to the phencyclidine (PCP) binding site of the N-methyl-D-aspartate (NMDA)-receptor in homogenates of postmortem human frontal cort
| Physical Appearance | A solid |
| Storage | Store at -20°C |
| M.Wt | 461.5 |
| Cas No. | 4682-36-4 |
| Formula | C18H23NO·C6H8O7 |
| Solubility | ≥23.07 mg/mL in DMSO; ≥2.74 mg/mL in EtOH with gentle warming and ultrasonic; ≥5.74 mg/mL in H2O with ultrasonic |
| Chemical Name | N,N-dimethyl-2-[(2-methylphenyl)-phenylmethoxy]ethanamine;2-hydroxypropane-1,2,3-tricarboxylic acid |
| SDF | Download SDF |
| Canonical SMILES | CC1=CC=CC=C1C(C2=CC=CC=C2)OCCN(C)C.C(C(=O)O)C(CC(=O)O)(C(=O)O)O |
| Shipping Condition | Small Molecules with Blue Ice, Modified Nucleotides with Dry Ice. |
| General tips | We do not recommend long-term storage for the solution, please use it up soon. |
Quality Control & MSDS
- View current batch:
Chemical structure
